Lake Bleu Capital — Full Portfolio
2 tracked investments · listed companies and verified rows first
Insilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development.
AI & Machine LearningBiotechDigital HealthHealthtechHong Kong, US
Aleksandrs Zavoronkovs(Executive Officer, Director)Alex Zavoronkov(Director)Alex Zhavoronkov(Founder)inAlex Aliper(President)inFeng Ren(Chief Scientific Officer, Executive Director & Co-CEO)in
BoardNisa Leung(Director)in
Co-investorsLilly Asia VenturesOrbiMedQiming Venture PartnersWarburg PincusBaidu VenturesEight Roads Ventures+16 more
Singleron Biotechnologies develops single-cell and single-nucleus sequencing kits and solutions for transcriptome analysis of biological samples.
BiotechMedical DevicesCologne, DE
Nan Fang(PhD, MBA; CEO and Founder)inJing Zhou(PhD; CSO (co-founder))inRong Fan(Co-Founder of Singleron, Professor Yale University)in
Co-investorsARCH Venture PartnersLAVLilly Asia VenturesMSA CapitalSBCVCSherpa Healthcare Partners+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.















